Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country

Subramaniam S 1 , Bhoo-Pathy N 2 , Taib NA , Tan GH , See MH , Jamaris S Show all authors , Ho GF , Looi LM , Yip CH

Affiliations 

  • 1 National Clinical Research Centre, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia, shridevi@crc.gov.my
  • 2
World J Surg, 2015 Oct;39(10):2450-8.
PMID: 26138872 DOI: 10.1007/s00268-015-3133-2

Abstract

Breast cancer can be divided into four subtypes based on the expressions of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor-2 (HER2). Each subtype has different clinicopathological features and outcomes.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications